Background illustration for clinical trials search

Paid Clinical Trials Memphis

Discover 522 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Memphis TN, Little Rock AR, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05061550

Phase2, Recruiting

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: Memphis TN, New Albany IN, Oklahoma City OK,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT07430306

Phase3, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Memphis TN, Bridgeton MO, Louisville KY, Newnan GA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Memphis TN, Little Rock AR, Paducah KY, Athens AL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Memphis TN, Tupelo MS, North Little Rock AR,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Memphis TN, Jackson TN, Little Rock AR, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

for
Dystonia
Location: Memphis TN, Nashville TN, Birmingham AL, St Louis MO,
Sponsor: Vima Therapeutics

Sex: All

Age: 18 - 65

Code: NCT07304089

Phase2, Recruiting

A Study of Buntanetap in Participants With PD

for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Memphis TN, Cordova TN, Birmingham AL, Tulsa OK,
Sponsor: Annovis Bio Inc.

Sex: All

Age: 40 - 70+

Code: NCT07284784

Phase2, Phase3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Memphis TN, West Monroe LA, Birmingham AL,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase3, Recruiting

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

for
Cutaneous Lupus Erythematosus (CLE),
Location: Memphis TN, Indianapolis IN, Allen TX, Saint Joseph MO,
Sponsor: Ventus Therapeutics U.S., Inc.

Sex: All

Age: 18 - 70+

Code: NCT07260877

Phase2, Recruiting

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

for
Obesity With Diabetes, Overweight With Diabetes
Location: Memphis TN, Little Rock AR, Cullman AL, Shreveport LA,
Sponsor: Kailera

Sex: All

Age: 18+

Code: NCT07284901

Phase3, Recruiting

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

for
Relapsed Myelodysplastic Syndrome,
Location: Memphis TN, Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06399640

Phase1, Recruiting

Telescope Exchange Study

for
Age-related Macular Degeneration
Location: Memphis TN, Springfield MO, Fort Worth TX, Ann Arbor MI,
Sponsor: VisionCare, Inc.

Sex: All

Age: 65+

Code: NCT03011554

Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Memphis TN, Little Rock AR, Nashville TN, Homewood AL,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase2, Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Memphis TN, Nashville TN, Irving TX, Houston TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase1, Phase2, Recruiting

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for
Brain Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer,
Location: Memphis TN, Nashville TN, Elizabethtown KY,
Sponsor: Adela, Inc

Sex: All

Age: 40+

Code: NCT05366881

Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for
AL Amyloidosis
Location: Memphis TN, Southhaven MS, Collierville TN, Oxford MS,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase3, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Memphis TN, Southhaven MS, Collierville TN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Memphis TN, Nashville TN, Birmingham AL, Saint Loius MO,
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT05911568

Recruiting

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Memphis TN, Southhaven MS, Collierville TN,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07383441

Phase3, Recruiting